The mobile gamma cameras market size is projected to be worth USD 59.5 billion in 2023. The market is likely to reach USD 89.8 billion by 2033. The market is further expected to surge at a CAGR of 4.2% during the forecast period 2023 to 2033.
Key Market Trends and Highlights
| Attributes | Key Insights |
|---|---|
| Mobile Gamma Cameras Market Estimated Size in 2023 | USD 59.5 billion |
| Projected Market Value in 2033 | USD 89.8 billion |
| Value-based CAGR from 2023 to 2033 | 4.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The scope for mobile gamma cameras rose at a 4.0% CAGR between 2018 and 2022. The global market for mobile gamma cameras is anticipated to grow at a moderate CAGR of 4.2% over the forecast period 2023 to 2033.
| Report Attribute | Details |
|---|---|
| Market Value in 2018 | USD 48.1 billion |
| Market Value in 2022 | USD 56.3 billion |
| CAGR from 2018 to 2022 | 4.0% |
The mobile gamma cameras market has witnessed significant changes in the transition from 2018 to 2022 to the forecast period from 2023 to 2033. During 2018 to 2022, the market experienced growth, due to factors such as driven by technological advancements, broader clinical adoption, and increasing healthcare investments globally.
Mobile gamma cameras found expanded applications in various medical fields, including cardiology, oncology, orthopedics, and neurology. The versatility of these devices contributed to their growing adoption. The rising incidence of chronic diseases, such as cardiovascular disorders and cancer, drove the demand for mobile gamma cameras for early diagnosis and treatment planning.
During 2023 to 2033, the market is projected to expand, owing to wider clinical adoption. Mobile gamma cameras are likely to be adopted in a broader range of clinical settings, including smaller clinics and outpatient facilities, due to their versatility and mobility. The integration of mobile gamma cameras with telemedicine and remote monitoring systems is expected to enhance patient care and enable real-time data sharing with healthcare professionals.
Mobile gamma cameras will play a vital role in the trend toward personalized medicine, facilitating targeted treatments based on individual patient characteristics and disease profiles. Artificial intelligence (AI) and machine learning applications in medical imaging will further improve the accuracy and speed of diagnosis with mobile gamma cameras.
Principal Consultant
The below table showcases revenues in terms of the top 5 leading countries, spearheaded by the United States and China. These two countries are expected to lead the market through 2033.
Market Share in 2022
| The United States | 83.9% |
|---|---|
| China | 25.0% |
| India | 15.0% |
| Japan | 22.0% |
| The United Kingdom | 15.0% |
Forecast CAGRs from 2023 to 2033
| The United States | 4.1% |
|---|---|
| China | 4.1% |
| India | 4.0% |
| Japan | 4.1% |
| The United Kingdom | 3.7% |
The mobile gamma cameras market in the United States is expected to expand at a CAGR of 4.1% through 2033. The country held a market share of 83.9% in 2022. The United States has a high prevalence of chronic diseases, such as cancer and heart disease. The demand for diagnostic tools like mobile gamma cameras to detect and monitor these conditions continues to grow, as the population ages.
The United States is a hub for medical technology innovation. Ongoing advancements in mobile gamma camera technology, including improved image quality and reduced radiation exposure, are driving adoption in the country.
The United States has a well-developed healthcare infrastructure, which includes hospitals, clinics, and imaging centers. The infrastructure supports the deployment and use of mobile gamma cameras for diagnostics and treatment planning.
Mobile gamma cameras trends in China are taking a turn for the better. A 4.1% CAGR is forecast for the country from 2023 to 2033. The country held a market share of 25.0% in 2022.
China has been investing significantly in its healthcare infrastructure, leading to an increase in the number of healthcare facilities and diagnostic centers that require advanced imaging equipment like mobile gamma cameras.
Manufacturers are introducing more advanced and mobile-friendly gamma cameras with improved imaging capabilities, making them attractive to healthcare providers in China. The ongoing urbanization in China has led to increased healthcare facilities in urban areas, where the demand for diagnostic imaging equipment is higher.
Growing healthcare awareness among the Chinese population and increased education about the benefits of early diagnosis contribute to the demand for diagnostic imaging services. Private healthcare providers in China are also investing in advanced medical equipment, including mobile gamma cameras, to attract patients seeking high-quality healthcare services.
The mobile gamma cameras market in India is poised to expand at a CAGR of 4.0% through 2033. India has a significant burden of chronic and non-communicable diseases, including cancer, cardiovascular diseases, and neurological disorders. The rising incidence of these diseases drives the demand for advanced diagnostic tools, including mobile gamma cameras.
The Indian government has launched various healthcare initiatives to improve access to quality healthcare services. The initiatives can create a conducive environment for the adoption of advanced medical imaging technologies.
India is a popular destination for medical tourism. The availability of state-of-the-art medical equipment, including mobile gamma cameras, contributes to the country's attractiveness as a healthcare destination. The country held a market share of 15.0% in 2022.
The Japan’s mobile gamma cameras market is anticipated to expand at a CAGR of 4.1% through 2033. Continuous advancements in gamma camera technology have made them more compact, mobile, and efficient. The advancements make mobile gamma cameras an attractive option for healthcare providers in Japan.
Both public and private healthcare providers in Japan are investing in state-of-the-art medical equipment to offer high-quality healthcare services. Mobile gamma cameras are essential in emergency medical services for rapid and accurate diagnosis of conditions like myocardial infarction. The integration of gamma cameras in ambulances is gaining traction.
Japan is known for its research and development activities in medical technology. Local manufacturers are developing innovative gamma camera systems, creating growth opportunities. Collaborations between Japanese healthcare institutions and international medical equipment manufacturers promote the adoption of advanced gamma camera systems. The country held a market share of 22.0% in 2022.
The mobile gamma cameras market in the United Kingdom is anticipated to expand at a CAGR of 3.7% through 2033. The United K has a rapidly aging population, leading to an increased prevalence of age-related health conditions, including cancer, cardiovascular diseases, and neurodegenerative disorders. Mobile gamma cameras play a crucial role in the diagnosis and management of these conditions, driving demand.
The National Health Service (NHS) is the publicly funded healthcare system in the United Kingdom, providing healthcare services to the majority of the population. The NHS's commitment to improving healthcare services and access to advanced diagnostic tools supports the growth of the mobile gamma cameras Market.
The country has embraced telemedicine and remote healthcare services, especially in rural and underserved areas. Mobile gamma cameras can be deployed in remote settings for diagnostic imaging and teleconsultations. The country held a market share of 15.0% in 2022.
The below table highlights how single head mobile gamma camera segment is projected to lead the market in terms of product type, and held a market share of 62.5% in 2022.
The hospitals segment of end-user is likely to spearhead sales, and held a market share of 41.0% in 2022.
| Category | Market Share in 2022 |
|---|---|
| Single Head Mobile Gamma Camera | 62.5% |
| Hospitals | 41.0% |
Based on product type, the single head mobile gamma camera segment is expected to continue dominating the mobile gamma cameras industry. The segment held a market share of 62.5% in 2022.
Single head mobile gamma cameras are typically more affordable than their multi-headed counterparts. The cost-effectiveness makes them an attractive option for healthcare facilities looking to invest in diagnostic imaging equipment without a significant financial burden.
Single head mobile gamma cameras are highly portable and easy to maneuver within healthcare settings. Their compact design allows for flexibility in positioning, making them suitable for various clinical environments, including smaller examination rooms.
The compact and less intimidating design of single head mobile gamma cameras can contribute to improved patient comfort and cooperation during imaging procedures. Patients may find these cameras less intimidating than larger, multi-headed systems.
Based on end-user, the hospitals segment is expected to continue dominating the mobile gamma cameras industry. The segment held a market share of 41.0% in 2022.
Hospitals are the primary healthcare institutions for diagnosing and treating a wide range of medical conditions, including cancer, cardiovascular diseases, and neurological disorders. The need for advanced diagnostic imaging equipment like mobile gamma cameras is rising, along with an increase in the patient admission rates.
Hospitals provide comprehensive medical care and are often equipped with various specialized departments, such as oncology and cardiology. Mobile gamma cameras are essential tools in these departments for diagnosing and monitoring diseases and conditions.
Hospitals offer emergency services, and mobile gamma cameras can be crucial in time-sensitive situations for rapid diagnosis and treatment planning, particularly in cases of trauma and acute illnesses.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Collaborations between manufacturers, end-users, and research institutions can lead to the development of innovative mobile gamma camera-based solutions for emerging applications.
The key strategies chosen by large companies include several growth strategies such as technology development, expansion as well and mergers and acquisitions to surge market share, reach and revenue.
| Attribute | Details |
|---|---|
| Estimated Market Size in 2023 | USD 59.5 billion |
| Projected Market Valuation in 2033 | USD 87.8 billion |
| Value-based CAGR 2023 to 2033 | 4.2% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Value in USD billion |
| Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East & Africa |
| Key Market Segments Covered | Product Type, Indication, End-User, Region |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel |
| Key Companies Profiled | Digirad Corporation; DDD-Diagnostic A/S; Dilon Technologies, Inc.; Spectrum Dynamics Medical; GAEDE; Medizinsysteme GmbH; Beijing Hamamatsu Photon Techniques Inc.; MIE America; Mediso; CLERAD; CardiArc |
The mobile gamma cameras market is expected to reach USD 59.5 billion in 2023.
The market for mobile gamma cameras is set to expand by a CAGR of 4.2% by 2033.
The mobile gamma cameras industry is forecast to reach USD 89.8 billion by 2033.
The United States is likely to be the top performing market, and to expand at a CAGR of 4.1% through 2033.
Single Head segment is preferred, and held a market share of 62.5% in 2022.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Single Head Mobile Gamma Camera 5.2. Double Head Mobile Gamma Camera 5.3. Triple Head Mobile Gamma Camera 5.4. Hand Held Mobile Gamma Camera 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 6.1. Cardiac Imaging 6.2. Breast Imaging 6.3. Hepatobiliary Imaging 6.4. GI Imaging 6.5. Renal Imaging 6.6. Brain Imaging 6.7. Others 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user 7.1. Hospitals 7.2. Ambulatory Surgical Centers 7.3. Cancer Research Institutes 7.4. Specialized Clinics 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Digirad Corporation 18.2. DDD-Diagnostic A/S 18.3. Dilon Technologies, Inc. 18.4. Spectrum Dynamics Medical 18.5. GAEDE Medizinsysteme GmbH 18.6. Beijing Hamamatsu Photon Techniques Inc. 18.7. MIE America 18.8. Mediso 18.9. CLERAD 18.10. CardiArc 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Mobile Gamma Cameras Market
